India bans 328 drugs in setback for pharma firms
By Reuters
September 14, 2018
NEW DELHI: The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but the ban has been cheered by health activists worried about growing antibiotic resistance due to the misuse of medicines.
The Indian government had in 2016 banned about 350 such drugs, referred to as fixed-dose combinations (FDCs), but the industry mounted various legal challenges that prompted the Supreme Court to call for a review by an advisory board.
The health ministry on Wednesday said the board had found there was "no therapeutic justification for the ingredients contained in 328 FDCs and that these FDCs may involve risk to human beings".
-
Princess Beatrice's Father-in-law Shares Cryptic Statement After Reports Her Marriage Is In Trouble -
Gen Z Juggles Multiple Jobs Using AI Tools -
Meghan Markle Turns Down Major Offer To Spill Royal Secrets -
Emperor Penguins On Verge Of Extinction: ‘A Grim Story Shaped By Climate Change’ -
Trump’s Ballroom Blunder: Why ‘America First’ Supporters Are Fuming -
Phoebe Dynevor Opens Up About 'panic Attacks' During ‘Thrash’ Filming -
Angelina Jolie's Daughter Shiloh Landed Music Video Project Under Stage Name -
Meghan Markle Starts 'long Game' With Secret Meetings As Duchess Isn't Giving Up On Britain -
Karol G Reveals When She Turns To Sofia Vergara -
NASA Artemis II Success Heats Up Lunar Race As China Targets 2030 Moon Landing -
Michael J. Fox Breaks Silence Over Death Rumors -
US Fertility Rate Drops To All-time Low In 2025: What It Means -
Kate Middleton, Prince William Send Meaningful Message To Meghan, Harry About Archie, Lilibet -
Carrie Underwood Defends Her ‘constructive Criticism’ On ‘American Idol’ -
Samsung Unpacked Event 2026 Rumoured To Reveal Galaxy Z Fold Series -
Archie, Lilibet Won't Join Prince Harry, Meghan To Australia Trip Amid Warning